Evidence map›Paper›PMID 39493896›Full record

ReviewBioImpacts : BI2024

COVID-19: An overview on possible transmission ways, sampling matrices and diagnosis.

Elina Armani Khatibi, Nastaran Farshbaf Moghimi, Elaheh Rahimpour

Abstract readReview
In one paragraph

Review in BioImpacts : BI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elina Armani KhatibiDepartment of Pharmaceutics, School of Pharmacy, Ardabil University of Medical Science, ‎Ardabil, Iran.ORCID https://orcid.org/0000-0001-6165-3177
Nastaran Farshbaf MoghimiDepartment of Pharmaceutics, School of Pharmacy, Ardabil University of Medical Science, ‎Ardabil, Iran.
Elaheh RahimpourPharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of ‎Medical Sciences, Tabriz, Iran.ORCID https://orcid.org/0000-0002-4037-9436

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is an RNA virus belonging to the SARS family of viruses and includes a wide range of symptoms along with effects on other body organs in addition to the respiratory system. The high speed of transmission, severe complications, and high death rate caused scientists to focus on this disease. Today, many different investigation types are performed on COVID-19 from various points of view in the literature. This review summarizes most of them to provide a useful guideline for researchers in this field. After a general introduction, this review is divided into three parts. In the first one, various transmission ways COVID-19 are classified and explained in detail. The second part reviews the used biological samples for the detection of virus and the final section describes the various methods reported for the diagnosis of COVID-19 in various biological matrices.

Indexed as

COVID-19Detection methodsInfectionSamplingTransmission

Identifiers

PMID39493896
PMCPMC11530968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.